Literature DB >> 15467460

Ras/Raf/ERK signalling and NF1.

Marie C Harrisingh1, Alison C Lloyd.   

Abstract

Ras signalling is important in the development of Schwann-cell-derived tumors in Neurofibromatosis Type 1 (NF1) patients. Schwann cells are a regenerative cell type, with no known stem-cell population. To produce new cells in the adult, for example following nerve damage, myelinating Schwann cells de-differentiate, proliferate and then re-differentiate during the repair process. We have found that Ras/Raf/ERK signalling can drive the de-differentiation of myelinated Schwann cells. In this review, we discuss how our results may contribute to the understanding of tumor formation in NF1 patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15467460     DOI: 10.4161/cc.3.10.1182

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  22 in total

1.  Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli.

Authors:  Nikos Tapinos; Anura Rambukkana
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

2.  Spontaneously regressing brain lesions in Smith-Lemli-Opitz syndrome.

Authors:  An N Dang Do; Eva H Baker; Katherine E Warren; Simona E Bianconi; Forbes D Porter
Journal:  Am J Med Genet A       Date:  2017-12-11       Impact factor: 2.802

3.  Overactivation of Ras signaling pathway in CD133+ MPNST cells.

Authors:  Emma Borrego-Diaz; Kaoru Terai; Kristina Lialyte; Amanda L Wise; Tuba Esfandyari; Fariba Behbod; Victor F Mautner; Melanie Spyra; Sarah Taylor; Luis F Parada; Meena Upadhyaya; Faris Farassati
Journal:  J Neurooncol       Date:  2012-04-08       Impact factor: 4.130

4.  Sustained MAPK/ERK Activation in Adult Schwann Cells Impairs Nerve Repair.

Authors:  Ilaria Cervellini; Jorge Galino; Ning Zhu; Shannen Allen; Carmen Birchmeier; David L Bennett
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

5.  Males with familial idiopathic scoliosis: a distinct phenotypic subgroup.

Authors:  Mark Clough; Cristina M Justice; Beth Marosy; Nancy H Miller
Journal:  Spine (Phila Pa 1976)       Date:  2010-01-15       Impact factor: 3.468

6.  Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpes.

Authors:  Faris Farassati; Weihong Pan; Farnaz Yamoutpour; Susann Henke; Mark Piedra; Silke Frahm; Said Al-Tawil; Wells I Mangrum; Luis F Parada; Samuel D Rabkin; Robert L Martuza; Andreas Kurtz
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

7.  NF1 loss disrupts Schwann cell-axonal interactions: a novel role for semaphorin 4F.

Authors:  Simona Parrinello; Luke A Noon; Marie C Harrisingh; Patrick Wingfield Digby; Laura H Rosenberg; Catherine A Cremona; Pedro Echave; Adrienne M Flanagan; Luis F Parada; Alison C Lloyd
Journal:  Genes Dev       Date:  2008-12-01       Impact factor: 11.361

8.  Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations.

Authors:  Navneet Sangha; Rong Wu; Rork Kuick; Scott Powers; David Mu; Diane Fiander; Kit Yuen; Hidetaka Katabuchi; Hironori Tashiro; Eric R Fearon; Kathleen R Cho
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

9.  Cyclin D3/CDK11(p58) complex involved in Schwann cells proliferation repression caused by lipopolysaccharide.

Authors:  Yinong Duan; Xingxin He; Huiguang Yang; Yuhong Ji; Tao Tao; Jinling Chen; Ling Hu; Fupeng Zhang; Xiaohong Li; Huimin Wang; Aiguo Shen; Xiang Lu
Journal:  Inflammation       Date:  2010-06       Impact factor: 4.092

10.  2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagy.

Authors:  Silvia Terés; Victoria Lladó; Mónica Higuera; Gwendolyn Barceló-Coblijn; Maria Laura Martin; Maria Antònia Noguera-Salvà; Amaia Marcilla-Etxenike; José Manuel García-Verdugo; Mario Soriano-Navarro; Carlos Saus; Ulises Gómez-Pinedo; Xavier Busquets; Pablo V Escribá
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.